WallStreetZen

NASDAQ: ENDP
Endo International plc Stock Forecast, Predictions & Price Target

Analyst price target for ENDP

Based on 3 analysts offering 12 month price targets for Endo International plc.
Min Forecast
$4.00+23.08%
Avg Forecast
$5.33+64.09%
Max Forecast
$7.00+115.38%

Should I buy or sell ENDP stock?

Based on 3 analysts offering ratings for Endo International plc.
Strong Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
2 analysts 66.67%

ENDP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
RBC Capital
Bottom 24%
24
HoldMaintains$5.00+53.85%2021-08-09
Morgan Stanley
Top 27%
74
Strong SellMaintains$7.00+115.38%2021-03-03
Anonymous
Morgan Stanley
Strong SellMaintains$4.00+23.08%2020-11-12

1 of 1

Forecast return on equity

Is ENDP forecast to generate an efficient return?
Company
-87.79%
Industry
101.53%
Market
2,530.69%
ENDP's Return on Equity is forecast to be low in 3 years (-87.79%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ENDP forecast to generate an efficient return on assets?
Company
5.88%
Industry
68.36%
Market
1,237.47%
ENDP is forecast to generate lower Return on Assets (5.88%) than the US Drug Manufacturers - Specialty & Generic industry average (68.36%)
Forecast

ENDP earnings per share forecast

What is ENDP's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$2.29+663.33%
Avg 2 year Forecast
$2.24+646.67%
Avg 3 year Forecast
$2.13+610%
ENDP's earnings are forecast to grow at an exceptional rate of 92.65% per year
Forecast

ENDP revenue forecast

What is ENDP's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$2.8B-2.25%
Avg 2 year Forecast
$2.7B-4.38%
Avg 3 year Forecast
$2.6B-6.5%
ENDP's revenue is forecast to grow at a rate of -2.22% per year, which is not exceptional
Forecast

ENDP earnings growth forecast

How is ENDP forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
92.65%
Industry
24.29%
Market
18.62%
ENDP's earnings are forecast to grow faster (92.65% per year) than the US Drug Manufacturers - Specialty & Generic industry average (24.29%)
Forecast
ENDP's earnings are forecast to grow faster (92.65% per year) than the US market average (18.62%)
Forecast
ENDP's earnings are forecast to grow faster (92.65% per year) than the risk-free savings rate (1.5%)
Forecast

ENDP revenue growth forecast

How is ENDP forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
-2.22%
Industry
24.41%
Market
12.38%
ENDP's revenues are forecast to grow slower (-2.22% per year) than the US Drug Manufacturers - Specialty & Generic industry average (24.41%)
Forecast
ENDP's revenues are forecast to grow slower (-2.22% per year) than the US market average (12.38%)
Forecast

Endo International Stock Forecast FAQ

Is Endo International Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ENDP) stock is to Strong Sell ENDP stock.

Out of 3 analysts, 0 (0%) are recommending ENDP as a Strong Buy, 0 (0%) are recommending ENDP as a Buy, 1 (33.33%) are recommending ENDP as a Hold, 0 (0%) are recommending ENDP as a Sell, and 2 (66.67%) are recommending ENDP as a Strong Sell.

What is ENDP's earnings growth forecast for 2021-2023?

(NASDAQ: ENDP) Endo International's forecast annual earnings growth rate of 92.65% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 24.29%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 18.62%.

Endo International's earnings in 2021 is $69,480,000.On average, 5 Wall Street analysts forecast ENDP's earnings for 2021 to be $534,715,641, with the lowest ENDP earnings forecast at $511,365,613, and the highest ENDP earnings forecast at $579,080,694. On average, 5 Wall Street analysts forecast ENDP's earnings for 2022 to be $523,040,627, with the lowest ENDP earnings forecast at $331,570,398, and the highest ENDP earnings forecast at $677,150,812.

In 2023, ENDP is forecast to generate $497,355,596 in earnings, with the lowest earnings forecast at $366,595,440 and the highest earnings forecast at $742,530,890.

What is ENDP's revenue growth forecast for 2021-2023?

(NASDAQ: ENDP) Endo International's forecast annual revenue growth rate of -2.22% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 24.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.38%.

Endo International's revenue in 2021 is $2,826,830,000.On average, 4 Wall Street analysts forecast ENDP's revenue for 2021 to be $645,203,303,690, with the lowest ENDP revenue forecast at $639,253,716,556, and the highest ENDP revenue forecast at $649,483,363,823. On average, 4 Wall Street analysts forecast ENDP's revenue for 2022 to be $631,152,891,342, with the lowest ENDP revenue forecast at $594,258,212,600, and the highest ENDP revenue forecast at $658,143,889,208.

In 2023, ENDP is forecast to generate $617,156,417,558 in revenue, with the lowest revenue forecast at $602,127,172,036 and the highest revenue forecast at $642,871,803,395.

What is ENDP's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: ENDP) forecast ROA is 5.88%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 68.36%.

What is ENDP's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ENDP price target, the average ENDP price target is $5.33, with the highest ENDP stock price forecast at $7.00 and the lowest ENDP stock price forecast at $4.00.

On average, Wall Street analysts predict that Endo International's share price could stay at $5.33 by Aug 9, 2022. The average Endo International stock price prediction forecasts a potential downside of N/A from the current ENDP share price of $3.25.

What is ENDP's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: ENDP) Endo International's current Earnings Per Share (EPS) is $0.30. On average, analysts forecast that ENDP's EPS will be $2.29 for 2021, with the lowest EPS forecast at $2.19, and the highest EPS forecast at $2.48. On average, analysts forecast that ENDP's EPS will be $2.24 for 2022, with the lowest EPS forecast at $1.42, and the highest EPS forecast at $2.90. In 2023, ENDP's EPS is forecast to hit $2.13 (min: $1.57, max: $3.18).

What is ENDP's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: ENDP) forecast ROE is -87.79%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.